Lack of association between vascular dementia and chlamydia pneumoniae infection: A case-control study

BMC Neurology

Volumn 4, Issue , 2004, Pages

  Carusone, Soo Chan ^a   Smieja, Marek ^a,b   Molloy, William ^a,c   Goldsmith, Charlie H ^a   Mahony, Jim ^a,b   Chernesky, Max ^a,b   Gnarpe, Judy ^d   Standish, Tim ^c   Smith, Stephanie ^a   Loeb, Mark ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c St Peter's Hospital   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; BIOLOGICAL MARKER;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CAREGIVER; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERIATRIC HOSPITAL; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIINFARCT DEMENTIA; PERSISTENT INFECTION; SEROLOGY; STATISTICAL SIGNIFICANCE; BLOOD; CHLAMYDOPHILA INFECTION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DEMENTIA, VASCULAR; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED;

EID: 12944275388     PISSN: 14712377     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2377-4-15     Document Type: Article

References (49)

1. Strub R: Vascular dementia. South Med J 2003, 96(4):363-366.
2. de Leeuw FE, van Gijn J: Vascular dementia. Practical Neurology 2003, 3:86-91.
3. Quinn J: Vascular dementia. J Am Med Dir Assoc 2003, 4(6 suppl):S155-S161.
4. Wilson CJ, Finch CE, Cohen HJ: Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002, 50:2041-2056.
5. Hull M, Strauss S, Berger M, Volk B, Bauer J: Inflammatory mechanisms in Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1996, 246(3):124-128.
6. Madre JG, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR, Martinez JD, Cenjor RF: Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002, 9(3):303-306.
7. Kawamoto R, Kajiwara T, Oka Y, Takagi Y: An association between an antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese. Intern Med 2003, 42(7): 71-575.
8. Wolf SC, Mayer O, Jürgens S, Vonthein R, Schultze G, Risler T, Brehm BR: Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003, 59(4):273-279.
9. Virok D, Kis Z, Karai L, Intzedy L, Burian K, Szabo A, Ivanyi B, Gonczol E: Chlamydia pneumoniae in artherosclerotic middle cerebral artery. Stroke 2001, 32(9):1973-1976.
10. Elkind MSV, Lin I-F, Grayston JT, Sacco RL: Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2000, 31(7):1521-1525.
11. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999, 30(2):299-305.
12. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998, 29(2):404-410.
13. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology 1993, 43(2):250-260.
14. Molloy DW, Alemayehu E, Roberts R: Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry 1991, 148: 02-105.
15. Wong BYL, Gnarpe J, Teo KK, Ohman EM, Prosser C, Gibler WB, Langer A, Chang W-C, Armstrong PW: Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. Am Heart J 2002, 144:987-994.
16. Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, Smith S, Borrie M, Decoteau E, Davidson W, McDougall A, Gnarpe J, O'Donnell M, Chernesky M: A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J Am Geriatr Soc 2004, 52:381-387.
17. Campbell LA, Kuo C-C, Grayston JT: Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 1998, 4(4 : 71-579.
18. Kalayoglu MV, Libby P, Byrne GI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002, 288(21):2724-2731.
19. Belland RJ, Ouellette SP, Gieffers J, Byrne GI: Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2004, 6(2):117-127.
20. Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G: Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 2003, 15(1-2):11-16.
21. Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong Y-K, Zhou X, Ward M: Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and metaanalysis. Eur Heart J 2002, 23:371-375.
22. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M: Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000, 321(7255): 208-213.
23. Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, Sweetnam PM, Elwood PC: Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study. BMJ 1999, 318(7190):1035-1040.
24. Breteler MM: Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000, 21:153-160.
25. Pansari K, Gupta A, Thomas P: Alzheimer's disease and vascular factors: facts and theories. Int J Clin Pract 2002, 56(3):197-203.
26. Shi J, Perry G, Smith MA, Friedland RP: Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000, 21:357-361.
27. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl) 1998, 187(1):23-42.
28. Gieffers J, Reusche E, Solbach W, Maass M: Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J Clin Microbiol 2000, 38(2):881-882.
29. Nochlin D, Shaw CM, Campbell LA, Kuo CC: Failure to detect Chlamydia pneumoniae in brain tissue of Alzheimer's disease. Neurology 1999, 53:1888.
30. Ring RH, Lyons JM: Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J Clin Microbiol 2000, 38(7):2591-2594.
31. Taylor GS, Vipond IB, Paul ID, Matthews S, Wilcock GK, Caul EO: Failure to correlate C. pneumoniae with late onset Alzheimer's disease. Neurology 2002, 59:142-143.
32. Wozniak MA, Cookson A, Wilcock GK, Itzhaki RF: Absence of Chlamydia pneumoniae in brain of vascular dementia patients. Neurobiol Aging 2003, 24(6):761-765.
33. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002, 52(2 ):168-174.
34. Strandberg TE, Tilvis RS: C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 2000, 20(4): 057-1060.
35. Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A: Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004, 35(1):163-168.
36. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JCM, Breteler MMB: Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004, 61:668-672.
37. McGeer PL, McGeer EG, Yasojima K: Alzheimer disease and neuroinflammation. J Neural Transm Suppl 2000, 59:53-57.
38. Yasojima K, Schwab C, McGeer EG, McGeer PL: Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 2000, 887(1):80-89.
39. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986, 2(8506):533-537.
40. Stott DJ, Spilg E, Campbell AM, Rumley A, Mansoor MA, Lowe GD: Haemostasis in ischaemic stroke and vascular dementia. Blood Coagul Fibrinolysis 2001, 12(8):651-657.
41. Mari D, Parnetti L, Coppola R, Bottasso B, Reboldi GP, Senin U, Mannucci PM: Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thromb Haemost 1996, 75(2): 16-218.
42. Bots ML, Breteler MMB, van Kooten F, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C: Coagulation and fibrinolysis markers and risk of dementia: the Dutch Vascular Factors in Dementia Study. Haemostasis 1998, 28:216-222.
43. Lowe GD, Haverkate F: Specificity of haemostasis abnormalities for vascular phenotypes. Haemostasis 1998, 28: 23-227.
44. Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S: Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation 2003, 107:251-257.
45. Smieja M, Mahony J, Petrich A, Boman J, Chernesky M: Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002, 2:21.
46. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 2003, 100(15):9090-9095.
47. von Känel R, Mills PJ, Fainman C, Dimsdale JE: Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001, 63:531-544.
48. Kiecolt-Glaser JK, Glaser R, Gravenstein S, Malarkey WB, Sheridan J: Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996, 93(7):3043-3047.
49. Vedhara K, Cox NK, Wilcock GK, Perks P, Hunt M, Anderson S, Lightman SL, Shanks NM: Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999, 353(9153):627-631.